COVID-19-Associated Liver Injury

This review analyzes data regarding liver injury associated with COVID-19 infection. We discuss reported effects on the liver from both COVID-19 and COVID-19 treatment as well as pathophysiology, review the potential role of drug-induced liver injury as an etiology of COVID-19-associated liver injur...

Descripción completa

Detalles Bibliográficos
Autores principales: Gildea, Daniel T, Woo, Stephanie M, O’Connor, Corinne E, Rangnekar, Amol S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960793/
https://www.ncbi.nlm.nih.gov/pubmed/36852138
http://dx.doi.org/10.2147/HMER.S384108
_version_ 1784895596051562496
author Gildea, Daniel T
Woo, Stephanie M
O’Connor, Corinne E
Rangnekar, Amol S
author_facet Gildea, Daniel T
Woo, Stephanie M
O’Connor, Corinne E
Rangnekar, Amol S
author_sort Gildea, Daniel T
collection PubMed
description This review analyzes data regarding liver injury associated with COVID-19 infection. We discuss reported effects on the liver from both COVID-19 and COVID-19 treatment as well as pathophysiology, review the potential role of drug-induced liver injury as an etiology of COVID-19-associated liver injury, and touch on other reports of significant outcomes including COVID-19 cholangiopathy and autoimmune hepatitis. Finally, we review the implications of COVID-19 infection in liver transplant recipients.
format Online
Article
Text
id pubmed-9960793
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-99607932023-02-26 COVID-19-Associated Liver Injury Gildea, Daniel T Woo, Stephanie M O’Connor, Corinne E Rangnekar, Amol S Hepat Med Review This review analyzes data regarding liver injury associated with COVID-19 infection. We discuss reported effects on the liver from both COVID-19 and COVID-19 treatment as well as pathophysiology, review the potential role of drug-induced liver injury as an etiology of COVID-19-associated liver injury, and touch on other reports of significant outcomes including COVID-19 cholangiopathy and autoimmune hepatitis. Finally, we review the implications of COVID-19 infection in liver transplant recipients. Dove 2023-02-21 /pmc/articles/PMC9960793/ /pubmed/36852138 http://dx.doi.org/10.2147/HMER.S384108 Text en © 2023 Gildea et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Gildea, Daniel T
Woo, Stephanie M
O’Connor, Corinne E
Rangnekar, Amol S
COVID-19-Associated Liver Injury
title COVID-19-Associated Liver Injury
title_full COVID-19-Associated Liver Injury
title_fullStr COVID-19-Associated Liver Injury
title_full_unstemmed COVID-19-Associated Liver Injury
title_short COVID-19-Associated Liver Injury
title_sort covid-19-associated liver injury
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960793/
https://www.ncbi.nlm.nih.gov/pubmed/36852138
http://dx.doi.org/10.2147/HMER.S384108
work_keys_str_mv AT gildeadanielt covid19associatedliverinjury
AT woostephaniem covid19associatedliverinjury
AT oconnorcorinnee covid19associatedliverinjury
AT rangnekaramols covid19associatedliverinjury

Ejemplares similares